Biotechnology Sector

In recent years, the landscape of global health insurance systems has undergone a significant transformation, catalyzed by the evolving needs of populations and the urgent demands for efficient healthcare delivery. Among these changes, Indonesia’s National Health Insurance scheme has become a focal point for analysis, serving as a valuable case study for health policy analysts

In a groundbreaking study poised to revolutionize the field of organ transplantation, researchers have harnessed the power of deep learning techniques to enhance the prediction of transplant recipient outcomes and improve pathology assessments through rapid analysis of procurement kidney biopsies. This innovative approach, detailed in the forthcoming publication in Scientific Reports, promises to address critical

In a groundbreaking development for the identification of Developmental Language Disorder (DLD), researchers have leveraged artificial intelligence (AI) to create a state-of-the-art screening application. This innovative app aims to enhance the accuracy and accessibility of DLD diagnosis, benefiting both practitioners in the field and families navigating the complexities of language disorders. The implications of this

In the rapidly evolving landscape of global commerce, the rise of cross-border e-commerce has transformed the way businesses operate. For many companies vying for market share in this competitive arena, traditional pricing strategies are becoming increasingly inadequate. To address the complexities of pricing and product selection, researchers have developed a new heuristic optimization framework known

A recent study published in BMC Endocrine Disorders has brought new insights into the complex relationship between adiponectin levels, glycemic control, and lipid profiles among Sudanese patients with type 2 diabetes mellitus. As the global prevalence of diabetes continues to rise, understanding the hormonal and metabolic factors that influence disease progression becomes increasingly important. This

In a groundbreaking study that illuminates the integration of traditional practices within modern medicine, researchers have explored indigenous knowledge and treatment modalities for post-traumatic joint stiffness and soft tissue contracture. This research is set against the backdrop of rural and urban communities in Tigray, Ethiopia, where the resilience and cultural heritage of the local population

In the rapidly evolving field of genomics, researchers are increasingly focused on the intricate relationship between genetic variants and phenotypic outcomes. A novel study conducted by a team led by Cao, Zhu, and Liang has taken a significant step forward in this area by constructing a robust genotype-phenotype network. This groundbreaking work not only sheds

Recent advancements in artificial intelligence are taking a bold leap into the realm of nursing education, as highlighted by a pioneering study conducted by Ibrahim, Shahrour, and Dukhaykh. This trailblazing research investigates the effects of experiential learning through AI-generated aging video simulations, delving deep into their impact on nursing students’ knowledge, attitudes, and gerontophobia. The

In a groundbreaking study conducted in Ankara, Türkiye, researchers have unveiled alarming insights into the exposure of preterm neonates to bisphenols—a group of industrial compounds known for their role in plastic manufacturing that have recently been scrutinized for their toxicological implications. This cohort study rigorously assessed bisphenol levels in a specified population of premature infants

A recent study sheds light on an urgent public health issue: the cost-effectiveness of primary prevention strategies to mitigate stroke risk among individuals with type 2 diabetes in the United States. With the diabetic population on the rise, understanding how to effectively allocate healthcare resources becomes paramount. The analysis led by a team of researchers,

In recent years, the field of biotechnology has witnessed exponential growth, particularly in the area of human organoids—miniaturized and simplified versions of organs that mimic their biological counterparts. These innovations promise to revolutionize medicine, providing unprecedented opportunities for studying diseases, drug testing, and personalized medicine. However, they also present a myriad of ethical and regulatory

C-type natriuretic peptide (CNP) has drawn attention in recent years due to its potential role in regulating physiological processes within the human body. In a groundbreaking study published in the Journal of Ovarian Research, researchers Wei, Deng, and Liu, et al., delved into the mechanisms through which CNP can alleviate apoptosis, particularly in ovarian granulosa

Uncertainty Among Caregivers of Individuals with Eating Disorders: Insights from Social Media Discourse In the digital age, social media platforms have become a vital source of information, support, and community for many facing various issues, including mental health challenges. One poignant area that has emerged as a focal point on platforms like Reddit is the

In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled a compelling link between metagenomic analyses and breast cancer through the investigation of E. coli-derived siderophores. This innovative research, led by Manzoor et al., suggests that these bacterial metabolites could serve as indicative signatures in the early detection and diagnosis of

In recent years, the focus on the health outcomes of older populations, particularly in emergency medical situations, has gained increasing importance. An illuminating study conducted in China sheds light on the prevalence of adverse health outcomes among older emergency patients, investigating the intricate web of factors that contribute to these outcomes. This study, led by

The human brain, with its intricate neural networks, continues to fascinate and baffle researchers, particularly in the realm of recovery following adverse events such as strokes. A recent scoping review highlighted in BMC Neuroscience delves into the role of the contralesional primary motor cortex in aiding upper limb recovery after a stroke. This development is

In a groundbreaking development that promises to reshape the landscape of artistic education, researchers Shi and Yu have introduced a sophisticated education system tailored for art creation, leveraging the innovative capabilities of generative adversarial networks (GANs). Their work highlights the transformative power of artificial intelligence in fostering creativity among aspiring artists. As the boundaries between

Financial toxicity in the context of pediatric cancer care is emerging as a critical concern for families grappling with the complexities of treatment and the accompanying economic burden. A recent study titled “Financial toxicity in pediatric cancer: lived experiences and coping strategies of parents,” conducted by Liu et al., sheds light on the multi-faceted experiences

In the realm of agricultural science, the emergence of new pathogens significantly disrupts crop production and threatens global food security. One such pathogen capturing the attention of researchers is Paramicrosphaeropsis eriobotryae, a newly identified canker pathogen affecting pomegranate trees. Research conducted by Sekandarpour, Negahban, Salami, and their colleagues delves deep into the pathogenic characteristics and

Recent research has intensified the spotlight on the often-overlooked experiences of autistic adults, especially regarding the pervasive yet underreported issue of anxiety. A systematic review conducted by researchers, including Da Silva, Berry, and Craig, delves into the qualitative dimensions of anxiety within this demographic. This extensive investigation not only catalogues the myriad ways in which

Explore our curated list of biotechnology-themed gifts, ranging from captivating board games to engaging DIY biology kits. The post Fifteen gift ideas for a biotech enthusiast this holiday season appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

After a year marked by dramatic ups and downs, William Blair analysts say 2026 could carry forward the industry’s current momentum—as long as strong clinical data continue to be rewarded and companies can bring drugs to market without major government pricing regulations.

Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success.

A key late-stage trial of Arcus Biosciences and Gilead’s anti-TIGIT antibody domvanalimab has flopped, leading Arcus to refocus its R&D priorities and abandon several trials of the drug.

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.

In this episode we sit down with Martin Beck, Senior Vice President and Head of the Inflammation Business Unit at Boehringer Ingelheim. The post Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the top spot at an obesity-focused biotech.

Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned approval application.

Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight loss and a 75.8% reduction in pain scores in patients with obesity and knee osteoarthritis. But the blowout efficacy was offset by a higher discontinuation rate than in an earlier retatrutide study.

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to four injectable therapies.

Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis and made the case for further development of its potentially disease-modifying therapy.

OTR may still be keeping its own pipeline under wraps, but Zealand has seen enough promise in the Chinese biotech’s platform to agree to hand over up to $30 million in upfront payments.

Two affiliates of Apple Tree Partners have filed for bankruptcy, a move designed to continue funding the venture firm's portfolio biotechs as a funding dispute with a top investor plays out.

Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. The post Promising cure for COPD: Is a breakthrough treatment within reach? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. Paris-based Sanofi is investing in a U.S. biotech’s autoimmune research, while GSK has tapped a fellow British outfit to discover new cancer antibodies.

Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset from Lynk Pharmaceuticals.

Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader to a 30% reduction in the risk of invasive disease recurrence or death.

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to advance its lead KRAS inhibitor into phase 3 studies.

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo. The post When AI isn’t enough: How physics is shaping the next wave of drug discovery  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless opportunities to leave behind the challenges of the real world for a bit of relaxation and maybe a little bit of magic.

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase 2 multiple myeloma trial, paving the way for smoother and more effective autologous stem cell transplants.

Ose Immunotherapeutics is prioritizing its lung cancer med Tedopi and its ulcerative colitis therapy lusvertikimab.

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences community. The post How world-class infrastructure will reinforce Ghent’s position as Europe’s biopharma hub appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Pfizer’s recent bidding war for an obesity biotech clearly hasn’t satiated the pharma’s appetite for new GLP-1 therapies—at least going by this morning’s $1.9 billion biobucks deal.

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to show superiority over existing treatments.

Novartis has tapped an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions.

GSK is walking away from Ideaya Biosciences after a five-year-long partnership that initially focused on three of Ideaya's synthetic lethality programs.

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals space in November. The post Top biotech deals in November 2025  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Novartis is divulging details from ianalumab’s phase 3 win in a rare autoimmune blood disorder, and the data suggest the treatment could delay the progression of patients to more serious forms of the disease

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025. The post The biggest biotech funding rounds in November 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

This week's guest is Mark Lanasa of BeOne Medicines and we will discuss their novel cancer models and unique in-house R&D approach. The post Cracking Cancer’s Code: Transforming Research with Novel Cancer Models appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal. The post Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

The biopharma ecosystem in Ireland incudes big pharmas as well as smaller native biotechs making a name in the region. The post Greener pastures for biopharma? Biotechs in Ireland causing a stir   appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Igyxos’ IGX12 brings a fresh approach to infertility treatment, aiming to improve outcomes for both men and women. The post Rethinking infertility treatment: Treating couples, not just women appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Delve into Vandria's technology and its Alzheimer's candidate, VNA-318, the first mitophagy-based candidate in Alzheimer's to reach the clinic. The post Vandria reports VNA-318’s first-in-human data in Alzheimer’s appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source

The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source

Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source

The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source

Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source

Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source

Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source

The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source

Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source

The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source

Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source

Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source

Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source

Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source

The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source

Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source

Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source

The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source

The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.

As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.